- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/50 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing
Patent holdings for IPC class G01N 33/50
Total number of patents in this class: 23312
10-year publication summary
1626
|
1914
|
1979
|
1974
|
1859
|
1699
|
1671
|
1464
|
1347
|
281
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19612 |
379 |
President and Fellows of Harvard College | 5897 |
232 |
The Board of Trustees of the Leland Stanford Junior University | 6262 |
191 |
Massachusetts Institute of Technology | 9925 |
188 |
The Johns Hopkins University | 5550 |
167 |
Dana-Farber Cancer Institute, Inc. | 2514 |
167 |
Centre National de La Recherche Scientifique | 10104 |
149 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3349 |
142 |
The General Hospital Corporation | 4652 |
138 |
Osaka University | 3320 |
126 |
F. Hoffmann-La Roche AG | 7884 |
120 |
The University of Tokyo | 4079 |
117 |
Regeneron Pharmaceuticals, Inc. | 4089 |
116 |
Immatics Biotechnologies GmbH | 1145 |
115 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2651 |
114 |
Kyoto University | 2770 |
111 |
Board of Regents, The University of Texas System | 5656 |
97 |
The Broad Institute, Inc. | 1731 |
88 |
Genentech, Inc. | 3861 |
85 |
The Brigham and Women's Hospital, Inc. | 2129 |
84 |
Other owners | 20386 |